{Reference Type}: Journal Article
{Title}: Repurposing indocyanine green: exploring the potential of an old drug in modern medicine.
{Author}: Sun X;Peng Y;He P;Cheng H;Li D;Liu H;Lin H;Liu G;
{Journal}: Nanoscale
{Volume}: 16
{Issue}: 24
{Year}: 2024 Jun 20
{Factor}: 8.307
{DOI}: 10.1039/d4nr00283k
{Abstract}: The repurposing of existing drugs, referred to as theranostics, has made profound impacts on precision medicine. Indocyanine green (ICG), a well-established and clinical dye, has continued to be a star agent, described as a multifunctional molecule with concurrent photo- or sono-sensitiveness capabilities and co-delivery accessibility, showing remarkable potential in the area of unimodal or multimodal imaging-guided therapy of various diseases, leading to the extensive consideration of immediate clinical translations. In this review, we strive to bring the understanding of repurposing performance assessment for ICG into practice by clarifying the relationships between its features and applicability. Specifically, we address the obstacles encountered in the process of developing an ICG repurposing strategy, as well as the noteworthy advancements made in the field of ICG repurposing. We also go into detail about the structure-function correlations of drugs containing ICG and how different structural groups significantly affect the physicochemical properties.